Delphinidin, Luteolin and Halogenated Boroxine Modulate CAT Gene Expression in Cultured Lymphocytes

Abstract

Luteolin and delphinidin are the flavonoids with known protective roles. They inhibit genotoxic effects induced by halogenated boroxine (HB) in vitro. Statistically significant decrease in the number of micronuclei and nuclear buds and decrease in proportion of abnormal cells were observed before, but mechanism of their anti-genotoxic activity is still not clear. In our experiment we aimed to quantify HB effects on the relative expression of CAT (catalase) gene and explore antioxidative effects of luteolin and delphinidin via restoration of CAT gene activity. Cell cultures from peripheral blood lymphocytes of five healthy donors were established and treated with single and combined treatments of HB with luteolin or delphinidin. Total RNA was isolated from harvested cells and reverse-transcribed. SYBR based Real-Time PCR amplification method was used. Relative gene expression measurements were done using normalization of ratio of target (CAT) and housekeeping (GAPDH) genes. Intergroup variance analysis was done with REST® software. Luteolin itself lead to downregulation of relative CAT gene expression as well as HB. But simultaneous treatment of HB and bioflavonoids lead to upregulation. Delphinidin as indenpendent treatment and as simultaneous treatment caused upregulation of relative CAT gene expression. Obtained results may suggest protective role of delphinidin and luteolin to oxidative-stress damage caused by HB, and also that new approaches to the treatment applications of HB should include bioflavonoids and monitoring corresponding antioxidant system. Our findings indicate that there is a quantifiable effect of luteolin and delphinidine on antioxidant genes which could be used in exact monitoring of oxidative stress related events.

In silico prediction suggests inhibitory effect of halogenated boroxine on human catalase and carbonic anhydrase

“…K 2 (B 3 O 3 F 4 OH) is a boron inorganic derivative formed in the reaction of potassium hydrofluoride (KHF 2 ) with boric acid, in a molar ratio of 2:3 [6]. Due to the lack of bioactivity research on halogenated boroxine (HB), a group of authors [7][8][9][10][11][12][13] conducted a study that tested the antiproliferative, cytotoxic, and genotoxic potential of dipotassium-trioxohydroxytetrafluorotriborate K 2 (B 3 O 3 F 4 OH) in human cell cultures. The results obtained by these analyses showed significant inhibitory effects of the tested concentrations of HB on cell growth in carcinoma cell cultures, which confirmed the antitumor potential [7,10,[14][15][16].…”

Investigation of the Exosome-Based Drug Delivery System Potential in theTreatment of Glioblastoma in vitro Experimental Models

“…However, studies on the use of exosomes as a drug delivery system are very few in the literature. These studies, on the other h, and, are mostly in the form of compilations [13,14].…”